Control of immunopathology during Plasmodium infection by hepcidin

Medical Hypotheses

Volumn 78, Issue 2, 2012, Pages 250-253

  Marguti, Ivo ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN;

ARTICLE; HEMOGLOBINOPATHY; IMMUNOPATHOLOGY; INFECTION CONTROL; INNATE IMMUNITY; IRON DEPLETION; MALARIA; NONHUMAN; PLASMODIUM; PROTEIN EXPRESSION;

ANIMALS; HEMOGLOBINOPATHIES; HEPCIDINS; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; IRON; MALARIA; MICE; PLASMODIUM;

MUS;

EID: 84855198995     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.10.038     Document Type: Article

References (57)

1. WHO, World Malaria Report 2010, (2010). http://www.who.int/malaria/world_malaria_report_2010/en/.
2. Haldar K., Murphy S.C., Milner D.A., Taylor T.E. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol 2007, 2:217-249.
3. Idro R., Jenkins N.E., Newton C.R. Pathogenesis clinical features and neurological outcome of cerebral malaria. Lancet Neurol 2005, 4:827-840.
4. Idro R., Marsh K., John C.C., Newton C.R. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res 2010, 68:267-274.
5. Rosenthal P.J., Meshnick S.R. Hemoglobin catabolism and iron utilization by malaria parasites. Mol Biochem Parasitol 1996, 83:131-139.
6. Coban C., Ishii K.J., Kawai T., Hemmi H., Sato S., Uematsu S., et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 2005, 201:19-25.
7. Parroche P., Lauw F.N., Goutagny N., Latz E., Monks B.G., Visintin A., et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci USA 2007, 104:1919-1924.
8. Coban C., Igari Y., Yagi M., Reimer T., Koyama S., Aoshi T., et al. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe 2010, 7:50-61.
9. Dostert C., Guarda G., Romero J.F., Menu P., Gross O., Tardivel A., et al. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One 2009, 4:e6510.
10. Franklin B.S., Ishizaka S.T., Lamphier M., Gusovsky F., Hansen H., Rose J., et al. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc Natl Acad Sci USA 2011, 108:3689-3694.
11. Yanez D.M., Manning D.D., Cooley A.J., Weidanz W.P., van der Heyde H.C. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 1996, 157:1620-1624.
12. Amante F.H., Haque A., Stanley A.C., Rivera Fde L., Randall L.M., Wilson Y.A., et al. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol 2010, 185:3632-3642.
13. Belnoue E., Kayibanda M., Vigario A.M., Deschemin J.C., van Rooijen N., Viguier M., et al. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol 2002, 169:6369-6375.
14. Nitcheu J., Bonduelle O., Combadiere C., Tefit M., Seilhean D., Mazier D., et al. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol 2003, 170:2221-2228.
15. Haque A., Best S.E., Unosson K., Amante F.H., de Labastida F., Anstey N.M., et al. Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J Immunol 2011, 186:6148-6156.
16. Haque A., Best S.E., Amante F.H., Mustafah S., Desbarrieres L., de Labastida F., et al. CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog 2010, 6:1001221.
17. Haldane J.B.S. The rate of mutation of human genes. Hereditas 1949, 35:267-273.
18. Lopez C., Saravia C., Gomez A., Hoebeke J., Patarroyo M.A. Mechanisms of genetically-based resistance to malaria. Gene 2010, 467:1-12.
19. Williams T.N. Human red blood cell polymorphisms and malaria. Curr Opin Microbiol 2006, 9:388-394.
20. Ayi K., Turrini F., Piga A., Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004, 104:3364-3371.
21. Fairhurst R.M., Fujioka H., Hayton K., Collins K.F., Wellems T.E. Aberrant development of Plasmodium falciparum in hemoglobin CC red cells: implications for the malaria protective effect of the homozygous state. Blood 2003, 101:3309-3315.
22. Cabrera G., Cot M., Migot-Nabias F., Kremsner P.G., Deloron P., Luty A.J. The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens. J Infect Dis 2005, 191:1631-1638.
23. Fairhurst R.M., Baruch D.I., Brittain N.J., Ostera G.R., Wallach J.S., Hoang H.L., et al. Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature 2005, 435:1117-1121.
24. Ferreira A., Marguti I., Bechmann I., Jeney V., Chora A., Palha N.R., et al. Sickle hemoglobin confers tolerance to Plasmodium infection. Cell 2011, 145:398-409.
25. Papanikolaou G., Tzilianos M., Christakis J.I., Bogdanos D., Tsimirika K., MacFarlane J., et al. Hepcidin in iron overload disorders. Blood 2005, 105:4103-4105.
26. Kearney S.L., Nemeth E., Neufeld E.J., Thapa D., Ganz T., Weinstein D.A., et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 2007, 48:57-63.
27. Origa R., Galanello R., Ganz T., Giagu N., Maccioni L., Faa G., et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 2007, 92:583-588.
28. Gardenghi S., Marongiu M.F., Ramos P., Guy E., Breda L., Chadburn A., et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 2007, 109:5027-5035.
29. Ganz T., Nemeth E. Hepcidin and disorders of iron metabolism. Annu Rev Med 2011, 62:347-360.
30. Andrews N.C., Schmidt P.J. Iron homeostasis. Annu Rev Physiol 2007, 69:69-85.
31. Viatte L., Lesbordes-Brion J.C., Lou D.Q., Bennoun M., Nicolas G., Kahn A., et al. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood 2005, 105:4861-4864.
32. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001, 98:8780-8785.
33. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grandchamp B., et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002, 99:4596-4601.
34. Roy C.N., Mak H.H., Akpan I., Losyev G., Zurakowski D., Andrews N.C. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 2007, 109:4038-4044.
35. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
36. She H., Xiong S., Lin M., Zandi E., Giulivi C., Tsukamoto H. Iron activates NF-kappaB in Kupffer cells. Am J Physiol Gastrointest Liver Physiol 2002, 283:G719-726.
37. Xiong S., She H., Takeuchi H., Han B., Engelhardt J.F., Barton C.H., et al. Signaling role of intracellular iron in NF-kappaB activation. J Biol Chem 2003, 278:17646-17654.
38. Ahmad K.A., Ahmann J.R., Migas M.C., Waheed A., Britton R.S., Bacon B.R., et al. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis 2002, 29:361-366.
39. Bahram S., Gilfillan S., Kuhn L.C., Moret R., Schulze J.B., Lebeau A., et al. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Proc Natl Acad Sci USA 1999, 96:13312-13317.
40. Zhou X.Y., Tomatsu S., Fleming R.E., Parkkila S., Waheed A., Jiang J., et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998, 95:2492-2497.
41. Wang L., Johnson E.E., Shi H.N., Walker W.A., Wessling-Resnick M., Cherayil B.J. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J Immunol 2008, 181:2723-2731.
42. Wang L., Harrington L., Trebicka E., Shi H.N., Kagan J.C., Hong C.C., et al. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest 2009, 119:3322-3328.
43. Wang L., Trebicka E., Fu Y., Ellenbogen S., Hong C.C., Babitt J.L., et al. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm Bowel Dis 2011.
44. Modiano D., Luoni G., Sirima B.S., Simpore J., Verra F., Konate A., et al. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 2001, 414:305-308.
45. Mockenhaupt F.P., Ehrhardt S., Cramer J.P., Otchwemah R.N., Anemana S.D., Goltz K., et al. Hemoglobin C and resistance to severe malaria in Ghanaian children. J Infect Dis 2004, 190:1006-1009.
46. Mockenhaupt F.P., Ehrhardt S., Gellert S., Otchwemah R.N., Dietz E., Anemana S.D., et al. Alpha(+)-thalassemia protects African children from severe malaria. Blood 2004, 104:2003-2006.
47. Allen S.J., O'Donnell A., Alexander N.D., Alpers M.P., Peto T.E., Clegg J.B., et al. alpha+Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 1997, 94:14736-14741.
48. Knutson M.D., Oukka M., Koss L.M., Aydemir F., Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci USA 2005, 102:1324-1328.
49. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation,and inflammation. J Clin Invest 2002, 110:1037-1044.
50. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002, 100:3776-3781.
51. De Domenico I., Zhang T.Y., Koening C.L., Branch R.W., London N., Lo E., et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 2010, 120:2395-2405.
52. Nyakeriga A.M., Troye-Blomberg M., Dorfman J.R., Alexander N.D., Back R., Kortok M., et al. Iron deficiency and malaria among children living on the coast of Kenya. J Infect Dis 2004, 190:439-447.
53. Sazawal S., Black R.E., Ramsan M., Chwaya H.M., Stoltzfus R.J., Dutta A., et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006, 367:133-143.
54. Trudel M., Saadane N., Garel M.C., Bardakdjian-Michau J., Blouquit Y., Guerquin-Kern J.L., et al. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J 1991, 10:3157-3165.
55. Trudel M., De Paepe M.E., Chretien N., Saadane N., Jacmain J., Sorette M., et al. Sickle cell disease of transgenic SAD mice. Blood 1994, 84:3189-3197.
56. Pinto J.P., Ribeiro S., Pontes H., Thowfeequ S., Tosh D., Carvalho F., et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 2008, 111:5727-5733.
57. Andrews N.C. Forging a field: the golden age of iron biology. Blood 2008, 112:219-230.